Next Article in Journal
Screening and Improvement of an Anti-VEGF DNA Aptamer
Previous Article in Journal
Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
Molecules 2010, 15(1), 198-214; doi:10.3390/molecules15010198
Article

Elucidating the Structure-Activity Relationships of the Vasorelaxation and Antioxidation Properties of Thionicotinic Acid Derivatives

1,* , 2, 3, 3, 4 and 3,*
Received: 11 November 2009; in revised form: 29 December 2009 / Accepted: 4 January 2010 / Published: 6 January 2010
Download PDF [215 KB, uploaded 18 June 2014]
Abstract: Nicotinic acid, known as vitamin B3, is an effective lipid lowering drug and intense cutaneous vasodilator. This study reports the effect of 2-(1-adamantylthio)nicotinic acid (6) and its amide 7 and nitrile analog 8 on phenylephrine-induced contraction of rat thoracic aorta as well as antioxidative activity. It was found that the tested thionicotinic acid analogs 6-8 exerted maximal vasorelaxation in a dose-dependent manner, but their effects were less than acetylcholine (ACh)-induced nitric oxide (NO) vasorelaxation. The vasorelaxations were reduced, apparently, in both NG-nitro-L-arginine methyl ester (L-NAME) and indomethacin (INDO). Synergistic effects were observed in the presence of L-NAME plus INDO, leading to loss of vasorelaxation of both the ACh and the tested nicotinic acids. Complete loss of the vasorelaxation was noted under removal of endothelial cells. This infers that the vasorelaxations are mediated partially by endothelium-induced NO and prostacyclin. The thionicotinic acid analogs all exhibited antioxidant properties in both 2,2-diphenyl-1-picrylhydrazyl (DPPH) and superoxide dismutase (SOD) assays. Significantly, the thionicotinic acid 6 is the most potent vasorelaxant with ED50 of 21.3 nM and is the most potent antioxidant (as discerned from DPPH assay). Molecular modeling was also used to provide mechanistic insights into the vasorelaxant and antioxidative activities. The findings reveal that the thionicotinic acid analogs are a novel class of vasorelaxant and antioxidant compounds which have potential to be further developed as promising therapeutics.
Keywords: 1-adamantylthionicotinic acid and derivatives; vasorelaxants; antioxidants; nitric oxide; prostacyclin; molecular modeling 1-adamantylthionicotinic acid and derivatives; vasorelaxants; antioxidants; nitric oxide; prostacyclin; molecular modeling
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Prachayasittikul, S.; Wongsawatkul, O.; Worachartcheewan, A.; Nantasenamat, C.; Ruchirawat, S.; Prachayasittikul, V. Elucidating the Structure-Activity Relationships of the Vasorelaxation and Antioxidation Properties of Thionicotinic Acid Derivatives. Molecules 2010, 15, 198-214.

AMA Style

Prachayasittikul S, Wongsawatkul O, Worachartcheewan A, Nantasenamat C, Ruchirawat S, Prachayasittikul V. Elucidating the Structure-Activity Relationships of the Vasorelaxation and Antioxidation Properties of Thionicotinic Acid Derivatives. Molecules. 2010; 15(1):198-214.

Chicago/Turabian Style

Prachayasittikul, Supaluk; Wongsawatkul, Orapin; Worachartcheewan, Apilak; Nantasenamat, Chanin; Ruchirawat, Somsak; Prachayasittikul, Virapong. 2010. "Elucidating the Structure-Activity Relationships of the Vasorelaxation and Antioxidation Properties of Thionicotinic Acid Derivatives." Molecules 15, no. 1: 198-214.


Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert